Biopharmaceuticals; pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of the following specific list of enumerated indications, autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders, diseases, conditions and disorders associated with misfolded proteins, diseases, conditions and disorders affecting the central nervous system, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host/graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.

Research services in the field of biotechnology.